NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
December 17, 2025 — CNS Pharmaceuticals appoints Rami Levin as new CEO to advance brain cancer drug pipeline. Leadership transition aims to accelerate development of TPI 287 for CNS tumors.
December 17, 2025 — Kairos Pharma wins 2025 Clinical Trials Arena Award for ENV-105, a CD105-targeting drug showing promise in resistant prostate cancer trials. Read about the breakthrough.
December 17, 2025 — Northwestern Medicine scientists discover USP22 biomarker predicting cancer immunotherapy resistance, published in The Journal of Clinical Investigation, with implications for personalized treatment.
December 17, 2025 — Oncotelic Therapeutics advances nanoparticle cancer therapy using Deciparticle platform. Learn how ultra-small carriers enhance drug delivery precision and effectiveness in oncology treatments.
December 17, 2025 — U.S. bill encourages AI adoption in hospitals for federal funding, sparking debate between modernization benefits and expert cautions about patient care and cost-cutting risks.
December 17, 2025 — GeoVax Labs completes fill-finish for GEO-MVA Mpox/smallpox vaccine, advancing toward Phase 3 trials in 2026. This milestone strengthens U.S. pandemic preparedness by diversifying vaccine supply.
December 17, 2025 — NeuroOne reports 907% Q4 revenue growth to $2.7M, FDA clearance for trigeminal nerve ablation system, and successful patient treatments. Medical technology advances for neurological disorders.
December 17, 2025 — CCHR documentary "Prescription for Violence" investigates links between psychiatric drugs and violent behavior, calling for transparency about medication risks and alternatives to drug-based treatments.
December 17, 2025 — AI is transforming the battle against drug-resistant infections. A new review reveals how machine learning predicts outbreaks, speeds diagnosis, optimizes treatment & discovers new antibiotics to save millions of lives.
December 17, 2025 — John Paul DeJoria joins PhytoTeq as advisor and investor to advance sustainable plant-based sugar technology that uses 98% less water and reduces carbon footprint.
December 17, 2025 — Neil Kelly's 2026 Home Design Trends Forecast reveals 9 key trends, including natural materials, wellness spaces, and warm colors, shaping how homeowners create grounding, restorative living environments.
December 17, 2025 — Designer Valicia Evans promotes everyday creativity for mental health, backed by research. Learn how small creative acts can reduce stress and boost wellbeing in her new interview.
December 17, 2025 — CleanGo Innovations announces acquisition of Freia Farmaceutici, expanding into plant-based therapeutics with vegetable omegas and medical devices for global health markets.
December 17, 2025 — A leading dentist debunks dangerous home fixes for chipped teeth like superglue, outlines emergency steps, and explains modern treatments including same-day dental crowns. Learn how to protect your smile.
December 16, 2025 — American Heart Association and Eggland's Best partner to release easy, heart-healthy breakfast recipes like Turkey Bacon Quiche and Egg Muffin Cups for busy families.
December 16, 2025 — UGI Utilities warns of rising carbon monoxide emergencies, urging customers to recognize poisoning symptoms and take preventive steps for safety. Learn more here.
December 16, 2025 — Jupiter Neurosciences achieves FDA clearance for JOTROL Parkinson's trial and launches Nugevia consumer line in 2025, backed by $20M funding and celebrity endorsements.
December 16, 2025 — Annovis Bio (NYSE: ANVS) hosts a corporate update webinar on therapies for Alzheimer's and Parkinson's diseases, featuring CEO Maria Maccecchini. Learn about clinical progress and strategic direction.
December 16, 2025 — Indian researchers challenge cancer treatment norms by taming glioblastoma tumors instead of destroying them. Study shows reduced cancer biomarkers and aggressiveness, with CNS Pharmaceuticals making related progress.
December 16, 2025 — GeoVax Labs receives patent for multi-antigen vaccine platform targeting three SARS-CoV-2 proteins for broader, longer-lasting protection against evolving viruses and improved pandemic preparedness.